Nicholas John Brandes, PA | |
Bldg 50, Farenholt Ave, Agana Heights,, GU 96910 | |
(671) 344-9340 | |
Not Available |
Full Name | Nicholas John Brandes |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Location | Bldg 50, Farenholt Ave, Agana Heights,, Guam |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144660929 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | 0110008809 (Virginia) | Primary |
1710I1002X | Military Health Care Provider - Independent Duty Corpsman | (* (Not Available)) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Nicholas John Brandes, PA Bldg 50, Farenholt Ave, Agana Heights,, GU 96910 Ph: (671) 344-9340 | Nicholas John Brandes, PA Bldg 50, Farenholt Ave, Agana Heights,, GU 96910 Ph: (671) 344-9340 |
News Archive
A microscopic gene may play a gigantic role when it comes to cancerous tissue in the human body, according to one Kansas State University research team.The team is investigating mutation within the ADAM12 gene of the A Disintegrin and Metalloprotease family, or ADAM family, and its role in breast cancer."We want to know whether ADAM12 is a good guy or a bad guy in breast cancer," said Anna Zolkiewska, associate professor of biochemistry and research team leader.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that significant T cell and antibody responses were generated in its Phase I clinical study of VGX-3400X, a SynCon DNA vaccine for the prevention of avian H5N1 influenza delivered using intramuscular (IM) electroporation.
Medical Research Council funded scientist Sir Martin Evans, has been awarded the Nobel Prize in Physiology or Medicine for 2007 alongside Mario R. Capecchi and Oliver Smithies for their discoveries of "principles for introducing specific gene modifications in mice by the use of embryonic stem cells".
Covidien, a leading global provider of healthcare products, today announced the launch of the Viance Crossing Catheter and Enteer Re-entry System for treating chronic total occlusions (CTOs) endovascularly.
› Verified 1 days ago